MedPath

Financial incentives for smoking and vaping cessation in South Australia: evaluation of the Incentive to Quit (I2Q) pilot program.

Not Applicable
Recruiting
Conditions
tobacco smoking
Mental Health - Addiction
Registration Number
ACTRN12624000395538
Lead Sponsor
Houd Research Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
450
Inclusion Criteria

Smokers, vapers and dual users are eligible for the I2Q program if they are:
•Attending one of the 4 participating NALHN services as an inpatient or outpatient between 03/04/2024 and 31/12/2024:
•Aboriginal health
•Mental health
•Cardiac health
•Respiratory health
•Daily smoker of at least 1 cigarette or equivalent (e.g. cigarillo, cigar, snuff) per day, OR 10 cigarettes per week
•OR regular” electronic cigarette (e-cig) user/vaper (noting regular” is self-reported by the patient as we do not yet have a clear definition of what constitutes regular vaping)
•At least 18 years of age
•Willing to make a quit attempt to stop smoking and/or vaping within 2 weeks of enrolment

Exclusion Criteria

Participants who are unable to communicate effectively in English will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Potential efficacy of the I2Q program to encourage smoker/vaper abstinence.[Biochemically validated abstinence, assessed via carbon monoxide testing for smokers, or saliva cotinine test for vapers. 3-month and 6-month follow-up post baseline enrolment.];Feasibility of the I2Q program by smokers/vapers[Reach: 1) Proportion of potentially eligible smokers who attend one of the three participating health service groups who are not enrolled in the I2Q program, as per data from study database 3-months and 6-months post baseline enrolment.];Feasibility of the I2Q program by smokers/vapers [Efficacy: 1) Self-reported (via survey designed specifically for this program) smoking quit attempts at 3-month follow-up and 6-month follow-up. 3-months and 6-months post baseline enrolment]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath